Volodymyr Kovalenko - Concepedia

Author

Volodymyr Kovalenko

Also Known As

Alina Kozliuk, Ilyas Atar, Mustafa Kemal Erol, Muzaffer Degertekin, V. Kovalenko, V. M. Kovalenko, V.M. Kovalenko, Volodymyr Kovalenko

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Celltrion (South Korea)Poznan University of Medical Sciences Hanyang University Seoul Hospital State Institution National Antarctic Scientific Center Inha University Hospital

About

Volodymyr Kovalenko is an author at Celltrion (South Korea) specializing in medicine, clinical nutrition, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	56
2	Public Health	1	1	18
3	Clinical Nutrition	1	1	18
4	Global Health	1	1	18
5	Nutrition	1	1	18

Volodymyr Kovalenko

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Dae‐Hyun Yoo, Paweł Hrycaj, Pedro C. Miranda, Annals of the Rheumatic Diseases	2013	650
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Won Park, Paweł Hrycaj, Volodymyr Kovalenko, Annals of the Rheumatic Diseases	2013	601
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis Dae‐Hyun Yoo, Chang‐Hee Suh, Seung Cheol Shim, Annals of the Rheumatic Diseases	2016	81
Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis Won Park, Chang‐Hee Suh, Seung Cheol Shim, BioDrugs Rheumatoid DisorderRheumatologyMedicineContinued TreatmentInflammatory Rheumatic Disease	2017	43
Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial Dae‐Hyun Yoo, Chang‐Hee Suh, Seung Cheol Shim, BioDrugs	2017	32
OP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis W. Park, Paweł Hrycaj, Volodymyr Kovalenko, Annals of the Rheumatic Diseases	2012	18
Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement N.V. Grygorievа, Volodymyr Kovalenko, N.V. Dedukh, PAIN JOINTS SPINE NutritionNutritional RequirementGlobal HealthClinical Nutrition25-Hydroxyvitamin D	2023	18
Guideline for diagnostic, prevention and treatment of postmenopausal osteoporosis N.V. Grygorievа, Volodymyr Kovalenko, N.V. Dedukh, PAIN JOINTS SPINE Bone DiseaseBone Turnover MarkersBone HealthMedicineGynecology	2023	13

Page 1